FDA authorization covers moderate-to-severe plaque psoriasis in adults and patients aged ≥12 years, expanding systemic options for adolescents. Icotrokinra is characterized as a first-in-class ...
This is the first IL-23 receptor-targeted oral peptide pill, and it is also being evaluated as a treatment for psoriatic arthritis, ulcerative colitis, and Crohn’s disease.
From a scrub to a TikTok-viral brush, these detoxifying treatments will give you a squeaky clean scalp and amazing hair.
The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, ...
Dermatologists and hair stylists share the best products for hair loss and thinning hair. Plus, they share how to prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results